Enhanced Protective Efficacy of a Novel, Thermostable, RBD-S2 Fusion Immunogen against SARS-CoV-2 and Its Variants

Mittal N, Kumar S, Rajmani RS, et al. Biophysics; 2023. doi:10.1101/2023.03.19.533338

VFI headquarters and Geneva laboratories

Rue du Champ-Blanchod 4
1228 Plan-les-Ouates
Switzerland

VFI Lausanne laboratories

Route de la Corniche 5
1066 Epalinges
Switzerland

contact@vformulation.org
VFI on LinkedIn

© 2025 Vaccine Formulation Institute